Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2007-02-20
2007-02-20
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S186100, C424S201100, C435S069100
Reexamination Certificate
active
10718264
ABSTRACT:
The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells and animals transformed by the vectors are provided. Methods for detecting the nucleic acids or polypeptides, and kits for diagnosing infection by a PWD circovirus, also are provided. Method for selecting compounds capable of modulating the viral infection are further provided. Pharmaceutical, including vaccine, compositions for preventing and/or treating viral infections caused by PWD circovirus and the use of vectors for preventing and/or treating diseases also are provided.
REFERENCES:
patent: 6143333 (2000-11-01), Ballam et al.
patent: 6217883 (2001-04-01), Allen et al.
patent: 6287856 (2001-09-01), Poet et al.
patent: 6368601 (2002-04-01), Allen et al.
patent: 6391314 (2002-05-01), Allan et al.
patent: 6497883 (2002-12-01), Bublot et al.
patent: 6517843 (2003-02-01), Ellis et al.
patent: 6660272 (2003-12-01), Allan et al.
patent: 2002/0055189 (2002-05-01), Bernhardt et al.
patent: 2002/0106639 (2002-08-01), Wang et al.
patent: 2002/0177216 (2002-11-01), Phillip et al.
patent: 2005/0058653 (2005-03-01), Ellis
patent: 10044648 (2002-03-01), None
patent: 2 422 956 (1979-11-01), None
patent: 2 518 755 (1983-06-01), None
patent: WO 90/11092 (1990-10-01), None
patent: WO 94/27238 (1994-11-01), None
patent: WO 95/11307 (1995-04-01), None
patent: WO 99/18214 (1999-04-01), None
patent: WO 00/77188 (2000-12-01), None
patent: WO 01/96377 (2001-12-01), None
patent: WO 02/102999 (2002-12-01), None
Allan, G.M. et al., 1995, Vet. Microbiol., 44: 49-64.
Barany, F., 1991, PNAS. USA, 88: 189-193.
Liu et al., 1997, J. Gen. Virol., 78 (Pt 6), 1265-1270.
Buckholz, R.G., 1993, Yeast systems for the expression of heterologous gene products. Curr. Op. Biotechnology 4: 538-542.
Burg, J.L. et al., 1996, Mol. and Cell. Probes, 10: 257-271.
Chu, B.C.F. et al., 1986, NAR, 14: 5591-5603.
Chu, P.W.G. et al., 1993, Virus Research, 27: 161-171.
Clark, E.G., 1997, American Association of Swine Practitioners, 499-501.
Daft, B. et al., 1996, American Association of Veterinary Laboratory Diagnosticians, 32.
Derse, D. et al., 1995, J. Virol., 69(3): 1907-1912.
Duck, P. et al., 1990, Biotechniques, 9: 142-147.
Dulac, G.C. et al., 1989, Can. J. Vet. Res., 53: 431-433.
Edwards, C.P., and Aruffo, A., 1993, Current applications of COS cell based transient expression systems. Curr. Op. Biotechnology 4: 558-563.
Edwards, S. et al., 1994, Vet. Rec., 134: 680-681.
Erlich, H.A., 1989, In PCR Technology. Principles and Applications for DNA Amplification. New York: Stockton Press.
Felgner, et al., 1987, Proc. Natl. Acad. Sci., 84: 7413-7417.
Fontes, E.P.B. et al., 1994, J. Biol. Chem., vol. 269, No. 11: 8459-8465.
Fraley et al., 1980, J. Biol. Chem., 255: 10431-10435.
Guateli, J.C. et al., 1990, Proc. Nat'l Acad. Sci., USA, 87: 1874-1878.
Hackland, A.F. et al., 1994, Arch. Virol., 139: 1-22.
Hanson, S.F. et al., 1995, Virology, 211: 1-9.
Harding, J.C., 1997, American Association of Swine Practitioners, 503.
Harding, R.M. et al., 1993, Journal of General Virology, 74: 323-328.
Harding, J.C. and Clark, E.G., 1997, Swine Health and Production, vol. 5, No. 5: 201-203.
Heyraud-Nitschke, F. et al., 1995, Nucleic Acids Research, vol. 23, No. 6: 910-916.
Horner, G.W., 1991, Surveillance 18(5): 23.
Müller, 1974, in Methode der Organischen Chemie, E. Wunsch Ed., vol. 15-I and 15-II, Thieme, Stuttgart.
Huygen, K. et al., 1996, Nature Medicine, 2(8): 893-898.
Innis, M.A. et al., 1990, in PCR Protocols. A guide to Methods and Applications, San Diego, Academic Press.
Kaneda, et al., 1989, Science, 243: 375-378.
Kievitis, T. et al., 1991, J. Virol. Methods, 35: 273-286.
Kohler, G. & Milstein, 1975, Nature, 256(5517): 495-497.
Kwoh, D.Y. et al., 1989, Proc. Nat'l Acad. Sci., USA, 86: 1173-1177.
Ladany, S. et al., 1989, J. Clin. Microbiol. 27: 2778-2783.
Lazarowitz, S.G. et al., 1989, The EMBO Journal, vol. 8 No. 4: 1023-1032.
Luckow, V.A., 1993, Baculovirus systems for the expression of human gene products. Curr. Op. Biotechnol. 4: 564-572.
Matthews, J.A. et al., 1988, Anal. Biochem., 169: 1-25.
McNeilly, F. et al., 1996, Vet. Immunol. Immunopathol., 49: 295-306.
Marglin, A. and Merrifield, R.B., 1966, J. Am. Chem. Soc., 88(21): 5051-5052.
Midoux, 1993, Nucleic Acids Research, 21: 871-878.
Miele, E.A. et al., 1983, J. Mol. Biol., 171: 281-295.
Virus Taxonomy, Murphy, F.A. et al., Ed. 1995, Sixth Report of the International Committee on Taxonomy of Viruses, Springer-Verlag Wien New York.
Nayar, G.P. et al., 1997, Can. Vet. J. 38(6): 385-386.
Olins, P.O., and Lee, S.C., 1993, Curr. Op. Biotechnol. 4: 520-525.
Pagano et al., 1967, J. Virol., 1: 891-897.
Rolfs, A. et al., “Usage of Polymerase Chain Reaction in Genetic and Infectious Disease” in PCR Topics, 1991, Springer-Verlag, Berlin.
Sambrook, J. et al., 1989, Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Sanchez-Pescador, R., 1988, J. Clin. Microbiol., 26(10): 1934-1938.
Kessler, C., “Overview of Amplification on Systems” in Non-radioactive Labeling and Detection of Biomolecules, 1992, Springer Verlag, Berlin, New-York: 197-205.
Shiver, J.W., “Immune Responses to HIV gp120 Elicited by DNA Vaccination,” in Vaccines, 1995, eds Chanock, et al., pp. 95-98, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
Tascon, R.E. et al., 1996, Nature Medicine, 2(8): 888-892.
Tischer, I. et al., 1982, Nature, 295: 64-66.
Tischer, I. et al., 1986, Arch. Virol., 91: 271-276.
Tischer, I. and Bohk, H.J., 1988, Zentralbl Bakteriol Mikrobiol Hyg [A] 270: 280-287.
Urdea, M.S., 1988, Nucleic Acids Research, 11: 4937-4957.
Walker, G.T. et al., 1992, Nucleic Acids Res. 20: 1691-1696.
Walker, G.T. et al., 1992, Proc. Nat'l Acad. Sci., USA, 89: 392-396.
White, B.A. et al. Eds, “PCR Cloning Protocol” in Methods in Molecular Biology, 67, Humana Press, Towota, 1997.
Zhao, T.M. et al., 1996, Proc. Natl. Acad. Sci., USA 93(13): 6653-6648.
Pearson, William R. et al., 1988, “Improved Tools for Biological Sequence Comparison”, Proc. Nat'l Acad, Sci., USA, 85: 2444-2448.
Kasahara, Noriyuki et al., 1994, “Tissue-Specific Targeting of Retroviral Vectors Through Ligan-Receptor Interactions”, Science, 266: 1373-1376.
Young, John A. T. et al., “Efficient Incorporation of Human CD4 Protein into Avian Leukosis Virus Particles”, Reports, 1421-1423.
Chu, Te-hua Terina et al., 1997, “Toward Highly Efficient Cell-Type-Specific Gene Transfer with Retroviral Vectors Displaying Single-Chain Antibodies”, J. Virol., 71(1): 720-725.
Smith, Temple F. et al., 1981, “Comparison of Biosequences”, Advances in Applied Mathematics, 2: 482-489.
Valsesia-Whittmann, Sandrine et al., 1996, “Improvement of Retroviral Retargeting by Using Amino Acid Spacers between an Additional Binding Domain and the N Terminus of Moloney Nurine Leukemia Virus SU”, J. Virol, 70(3): 2059-2064.
Neddleman, Saul B. et al., 1970, “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins”, J. Mol. Biol., 48(3): 443-453.
Cosset, Francois-Loic et al., 1995, “Retroviral Retargeting by Envelopes Expressing an N-Terminal Binding Domain”, J. Virol., 69:6314-6322.
Blanchard et al., 2003, “An ORF2 Protein-Based ELISA for Procine Circovirus Type 2 Antibodies in Post-Weaning Multisystemic Wasting Syndrome”, Veterinary Microbiology, 94: 183-184.
Rose, N. et al., 2002, “Risk Factors for Porcine Post-Weaning Multisystemic Wasting Syndrome (PMWS) in 149 French Farrow-to-Finish Herds”, Preventive Veterinary Microbiology, 61: 209-225.
Blanchard et al., 2003, “Protection of Swine Against Post-Weaning Multisystemic Wasting Syndrome (PMWS) by Porcine Circovirus Type 2 (PCV2) Proteins”, Vaccine 21: 4565-4575.
Derwent Abstract of French Patent Appl. No. 2422956.
D
Albina Emmanuel
Arnauld Claire
Blanchard Philippe
Cann Pierre Le
Cariolet Roland
Bingham & McCutchen LLP
Crane Sharon E.
Salimi Ali R.
Wyeth
LandOfFree
Circovirus sequences associated with piglet weight loss... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Circovirus sequences associated with piglet weight loss..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Circovirus sequences associated with piglet weight loss... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3845283